Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus
- 21 January 2005
- Vol. 23 (24), 3139-3147
- https://doi.org/10.1016/j.vaccine.2004.12.023
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Aerosol Infection of Cynomolgus Macaques with Enzootic Strains of Venezuelan Equine Encephalitis VirusesThe Journal of Infectious Diseases, 2004
- Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal modelsVaccine, 2003
- Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected miceVirus Research, 2003
- Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitisJournal of Neuroimmunology, 2002
- Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated miceVaccine, 2001
- Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN miceVaccine, 1997
- Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccineVaccine, 1996
- Attenuated Mutants of Venezuelan Equine Encephalitis Virus Containing Lethal Mutations in the PE2 Cleavage Signal Combined with a Second-Site Suppressor Mutation in E1Virology, 1995
- Phylogenetic analysis of alphaviruses in the venezuelan equine encephalitis complex and identification of the source of epizootic virusesVirology, 1992
- Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitisNature, 1982